Theriva Biologics, Inc. (TOVX) — Institutional Holders, Q2 2026
26 institutional investment managers reported a TOVX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $495.5K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
TOVX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- VANGUARD CAPITAL MANAGEMENTAdded · +293,775 sh+$73.5K
- JANE STREET GROUPAdded · +154,888 sh+$38.8K
- NORTHERNNew · +82,700 sh+$20.7K
- RENAISSANCE TECHNOLOGIESNew · +63,710 sh+$15.9K
- Ground Swell CapitalNew · +35,292 sh+$8.8K
Biggest sellers
- Virtu FinancialTrimmed · -166,080 sh-$41.6K
- UBS Group AGTrimmed · -164,571 sh-$41.2K
- GEODE CAPITAL MANAGEMENTTrimmed · -156,242 sh-$39.1K
- TWO SIGMA SECURITIESTrimmed · -85,493 sh-$21.4K
- XTX Topco LtdTrimmed · -40,752 sh-$10.2K
TOVX 13F holders ranked 1–26 of 26
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT#1 · 486,179 sh | 486,179 | $121.5K | 0.00% | +152.7% |
| 2 | JANE STREET GROUP#2 · 331,922 sh | 331,922 | $83.0K | 0.00% | +87.5% |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 294,021 sh | 294,021 | $73.6K | 0.00% | -34.7% |
| 4 | VANGUARD FIDUCIARY#4 · 241,780 sh | 241,780 | $60.4K | 0.00% | 0.0% |
| 5 | Ikarian Capital#5 · 112,076 sh | 112,076 | $28.0K | <0.01% | 0.0% |
| 6 | Virtu Financial#6 · 87,138 sh | 87,138 | $22.0K | <0.01% | -65.6% |
| 7 | NORTHERN#7 · 82,700 sh | 82,700 | $20.7K | 0.00% | New |
| 8 | RENAISSANCE TECHNOLOGIES#8 · 63,710 sh | 63,710 | $15.9K | 0.00% | New |
| 9 | UBS Group AG#9 · 61,053 sh | 61,053 | $15.3K | 0.00% | -72.9% |
| 10 | XTX Topco Ltd#10 · 53,868 sh | 53,868 | $13.5K | <0.01% | -43.1% |
| 11 | Ground Swell Capital#11 · 35,292 sh | 35,292 | $8.8K | <0.01% | New |
| 12 | BOOTHBAY FUND MANAGEMENT#12 · 27,646 sh | 27,646 | $6.9K | <0.01% | 0.0% |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#13 · 24,064 sh | 24,064 | $6.0K | 0.00% | New |
| 14 | MORGAN STANLEY#14 · 20,299 sh | 20,299 | $5.1K | 0.00% | -14.0% |
| 15 | TWO SIGMA SECURITIES#15 · 19,748 sh | 19,748 | $4.9K | <0.01% | -81.2% |
| 16 | TWO SIGMA INVESTMENTS#16 · 15,456 sh | 15,456 | $3.9K | 0.00% | +0.1% |
| 17 | SCHWARZ DYGOS WHEELER INVESTMENT ADVISORS#17 · 15,000 sh | 15,000 | $3.8K | <0.01% | 0.0% |
| 18 | BlackRock#18 · 7,504 sh | 7,504 | $1.9K | 0.00% | 0.0% |
| 19 | OSAIC#19 · 441 sh | 441 | $110.00 | 0.00% | +5412.5% |
| 20 | SBI Securities , Ltd.#20 · 358 sh | 358 | $90.00 | — | +173.3% |
| 21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT#21 · 100 sh | 100 | $25.00 | 0.00% | New |
| 22 | IFP Advisors#22 · 11 sh | 11 | $3.00 | — | 0.0% |
| 23 | Newbridge Financial Services Group#23 · 5 sh | 5 | $1.00 | — | 0.0% |
| 24 | BARCLAYS PLC#24 · 3 sh | 3 | $1.00 | 0.00% | New |
| 25 | ROYAL BANK OF CANADA#25 · 1 sh | 1 | $0.00 | 0.00% | 0.0% |
| 26 | DANSKE BANK A/S#26 · 1 sh | 1 | $0.00 | 0.00% | 0.0% |
Funds that sold out of TOVX in Q2 2026 (2)
Held TOVX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| StoneX Group22,280 sh | 22,280 | $4.4K |
| CITIGROUP1,391 sh | 1,391 | $272.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.